Description
IBRUTINIB (IMBRUVICAN) 140 MG 90'S
First action · last action
2014-09-05 · 2014-09-08
Transactions
2
First transaction's obligation
$24,417
Base + all options value (sum of deltas)
$24,429
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-09-05+$24,417= $24,417
- Mod P000012014-09-08+$12= $24,429
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-09-05 | +$24,417 | $24,417 | IBRUTINIB (IMBRUVICAN) 140 MG 90'S |
| Mod P00001· CHANGE ORDER | 2014-09-08 | +$12 | $24,429 | IBRUTINIB (IMBRUVICAN) 140 MG 90'S |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CKC8F2RMF1K6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA26215F0384 | 262-NETWORK CONTRACT OFFICE 22 · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2015 |
| VA24514P2357 | 512-BALTIMORE · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2014 |
| VA69D14P4818 | 69D-NETWORK CONTRACT OFFICE 12 · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2014 |
| VA24714C0418 | 247-NETWORK CONTRACT OFFICE 7 · 6505 · DRUGS AND BIOLOGICALS | $6,107 | FY2014 |
| VA24614P7155 | 246-NETWORK CONTRACTING OFFICE 6 · 6505 · DRUGS AND BIOLOGICALS | $36,644 | FY2014 |
| VA24614P7198 | 246-NETWORK CONTRACTING OFFICE 6 · 6505 · DRUGS AND BIOLOGICALS | $97,718 | FY2014 |
Other recipients under 6505 from 603-LOUISVILLE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24916J2015 | APHENA PHARMA SOLUTIONS-TENNESSEE, LLC | 603-LOUISVILLE | $3,081 | FY2016 |
| VA24916J1966 | GRIFOLS THERAPEUTICS LLC | 603-LOUISVILLE | $4,596 | FY2016 |
| VA24916J1860 | GRIFOLS THERAPEUTICS LLC | 603-LOUISVILLE | $22,627 | FY2016 |
| VA24916J1713 | ACTELION PHARMACEUTICALS US, INC. | 603-LOUISVILLE | $6,438 | FY2016 |
| VA24916P1622 | CAREMARK RX, L.L.C. | 603-LOUISVILLE | $6,255 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24914F3992_3600_-NONE-_-NONE- · retrieved 2026-09-26.